Form 8-K · Current report
News Corp 8-K, filed Sep 29, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000211
Summary
News Corp filed an 8-K reporting daily ASX buy-back disclosures under its 2025 Repurchase Program, which authorizes up to $1 billion in aggregate repurchases of its Nasdaq-listed Class A and Class B common stock. As of the previous day, the company had repurchased about $501.6 million worth of Class A and Class B shares under the program.
Key points
- News Corp repurchased 62,323 shares on 28/09/2026 for total consideration of US$1,783,385.11.
- Cumulative repurchases under the 2025 Repurchase Program totaled 12,484,357 shares for US$326,985,205.98 at the time of the notification, excluding the prior day's purchases.
- The 2025 Repurchase Program, authorized as of July 15, 2025, permits repurchases of up to an aggregate US$1 billion of Class A and Class B common stock, with Goldman Sachs & Co. LLC as broker.
- The company has purchased approximately US$501,577,975 worth of Class A and Class B shares under the program to date.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.